Efficacy and safety of tralokinumab in adolescents with moderate-to- severe atopic dermatitis: results of the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s29, 2022. DOI: 10.25251/skin.6.supp.s29. Disponível em: https://skin.dermsquared.com/skin/article/view/1546. Acesso em: 24 jun. 2025.